• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
Marin Wealth Advisors, LLC.

Marin Wealth Advisors, LLC.

Registered investment Advisor

  • Investment Advice
    • Help with Your Investments
    • Investment Standards
    • ESG Investing
  • Financial Planning
    • Stock Compensation Advisors
    • 529 College Savings Plan
    • Estate Planning
    • MWA Personal Financial Coach
  • Retirement Planning
    • Retirement Financial Advisor
    • Employer 401K Plans
    • IRA Rollover Accounts
    • Business Retirement Plans
  • MWA Online Advisor
  • About
  • Blog
  • Contact
  • CLient Portal
  • Investment Advice
    • Help with Your Investments
    • Investment Standards
    • ESG Investing
  • Financial Planning
    • Stock Compensation Advisors
    • 529 College Savings Plan
    • Estate Planning
    • MWA Personal Financial Coach
  • Retirement Planning
    • Retirement Financial Advisor
    • Employer 401K Plans
    • IRA Rollover Accounts
    • Business Retirement Plans
  • MWA Online Advisor
  • About
  • Blog
  • Contact
  • CLient Portal

Blog

September 28, 2015

Test Time?

In my last post, “Got Volatility?” I proposed that the S&P 500 may be trying to establish a trading range between roughly 1800 and 2000, and that a successful test of the August 24th low of 1867, with fewer stocks posting new low prices, would be a sign of strength.

This morning we are down for the 7th day out of the last 8 and pressing down on 1900 on the S&P, which is now 10% off (including dividends) from its May high. This feels like the beginning of our test of the late August lows. Building a base in markets requires these tests of previous lows. In other words it’s normal at this point.

The biotech index is off over 25% from its July high. Biotech has been one of the last industry groups to roll over since the market started to weaken under the surface early this year. IBB, the biotech index ETF most widely followed, is currently testing $300, down from $400 in July. (The August 24th low was $284.) Fears of political pressure on product pricing seems to be part of the selloff, but much of it also seems a classic run for the exits by the momentum players.

We’ll be watching market internals as we continue this test of recent market lows. In spite of the negative news flow there are some hopeful technical signs that the market is starting to heal. In the meantime many of the price excesses are being purged as the market backs and fills. As well, we’ll be posting more frequently while the market is being challenged.

 

 

Category iconInvestment Management Tag iconETFs,  Mutual Funds,  Stocks

Primary Sidebar

Recent Posts

  • Market Recap Week Ending January 22
  • Market Recap Week Ending January 15th
  • Market Recap Week Ending January 1
  • Market Recap Week Ending December 18th
  • Market Recap Week Ending December 11th

Categories

  • Asset Allocation (1)
  • ESG Investing (1)
  • Estate Planning (4)
  • Financial Planning (10)
  • Investment Management (42)
  • Investments (18)
  • Retirement Planning (12)
  • Stock Compensation (2)
  • Uncategorized (18)

Working With Marin Wealth Advisors

Fee-only Investment Management
Financial Planning at an hourly rate
No commission, no conflict of interest

Request a free one-hour financial review